810 related articles for article (PubMed ID: 11473107)
1. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.
Phiel CJ; Zhang F; Huang EY; Guenther MG; Lazar MA; Klein PS
J Biol Chem; 2001 Sep; 276(39):36734-41. PubMed ID: 11473107
[TBL] [Abstract][Full Text] [Related]
2. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
Leng Y; Chuang DM
J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
[TBL] [Abstract][Full Text] [Related]
3. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
[TBL] [Abstract][Full Text] [Related]
4. A common mechanism of action for three mood-stabilizing drugs.
Williams RS; Cheng L; Mudge AW; Harwood AJ
Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
[TBL] [Abstract][Full Text] [Related]
5. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
[TBL] [Abstract][Full Text] [Related]
6. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
7. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition.
Jeong MR; Hashimoto R; Senatorov VV; Fujimaki K; Ren M; Lee MS; Chuang DM
FEBS Lett; 2003 May; 542(1-3):74-8. PubMed ID: 12729901
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line.
Balasubramanian D; Deng AX; Doudney K; Hampton MB; Kennedy MA
Neuropharmacology; 2015 Dec; 99():79-88. PubMed ID: 26151765
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase.
Johansson AS; Brask J; Owe-Larsson B; Hetta J; Lundkvist GB
J Biol Rhythms; 2011 Dec; 26(6):541-51. PubMed ID: 22215612
[TBL] [Abstract][Full Text] [Related]
11. Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase.
Wu G; Nan C; Rollo JC; Huang X; Tian J
J Biomed Sci; 2010 Mar; 17(1):16. PubMed ID: 20219112
[TBL] [Abstract][Full Text] [Related]
12. Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition.
Shi Y; Gerritsma D; Bowes AJ; Capretta A; Werstuck GH
Bioorg Med Chem Lett; 2007 Aug; 17(16):4491-4. PubMed ID: 17566732
[TBL] [Abstract][Full Text] [Related]
13. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
[TBL] [Abstract][Full Text] [Related]
14. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
[TBL] [Abstract][Full Text] [Related]
15. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera.
Sasaki K; Yamagata T; Mitani K
Cancer Sci; 2008 Feb; 99(2):414-22. PubMed ID: 18271940
[TBL] [Abstract][Full Text] [Related]
18. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo.
Gurvich N; Berman MG; Wittner BS; Gentleman RC; Klein PS; Green JB
FASEB J; 2005 Jul; 19(9):1166-8. PubMed ID: 15901671
[TBL] [Abstract][Full Text] [Related]
19. Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3.
Leng Y; Wang J; Wang Z; Liao HM; Wei M; Leeds P; Chuang DM
Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207921
[TBL] [Abstract][Full Text] [Related]
20. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers.
Vulcano F; Ciccarelli C; Mattia G; Marampon F; Giampiero M; Milazzo L; Pascuccio M; Zani BM; Giampaolo A; Hassan HJ
Exp Cell Res; 2006 May; 312(9):1590-7. PubMed ID: 16739251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
